Materials Today Bio (Jun 2024)

Replenishment of mitochondrial Na+ and H+ by ionophores potentiates cutaneous wound healing in diabetes

  • Liangliang Bai,
  • Linping Wu,
  • Changsheng Zhang,
  • Zhiwen Liu,
  • Liang Ma,
  • Jing Ni,
  • Dezhen He,
  • Mingxuan Zhu,
  • Shaoyong Peng,
  • Xiaoxia Liu,
  • Huichuan Yu,
  • Yuhe Lei,
  • Yanxin Luo,
  • Yu Zhang,
  • Xiaolin Wang,
  • Gang Wei,
  • Yingjie Li

Journal volume & issue
Vol. 26
p. 101056

Abstract

Read online

Diabetic foot ulcer (DFU) is a highly morbid complication in patients with diabetes mellitus, necessitating the development of innovative pharmaceuticals to address unmet medical needs. Sodium ion (Na+) is a well-established mediator for membrane potential and osmotic equilibrium. Recently, Na+ transporters have been identified as a functional regulator of regeneration. However, the role of Na+ in the intricate healing process of mammalian wounds remains elusive. Here, we found that the skin wounds in hyponatremic mice display a hard-to-heal phenotype. Na+ ionophores that were employed to increase intracellular Na+ content could facilitate keratinocyte proliferation and migration, and promote angiogenesis, exhibiting diverse biological activities. Among of them, monensin A emerges as a promising agent for accelerating the healing dynamics of skin wounds in diabetes. Mechanistically, the elevated mitochondrial Na+ decelerates inner mitochondrial membrane fluidity, instigating the production of reactive oxygen species (ROS), which is identified as a critical effector on the monensin A-induced improvement of wound healing. Concurrently, Na+ ionophores replenish H+ to the mitochondrial matrix, causing an enhancement of mitochondrial energy metabolism to support productive wound healing programs. Our study unfolds a new role of Na+, which is a pivotal determinant in wound healing. Furthermore, it directs a roadmap for developing Na+ ionophores as innovative pharmaceuticals for treating chronic dermal wounds in diabetic patients.

Keywords